These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10859580)

  • 1. Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis.
    Lafata JE; Martin SA; Kaatz S; Ward RE
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S13-9. PubMed ID: 10859580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.
    Lafata JE; Martin SA; Kaatz S; Ward RE
    J Gen Intern Med; 2000 Jan; 15(1):31-7. PubMed ID: 10632831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling.
    Connock M; Stevens C; Fry-Smith A; Jowett S; Fitzmaurice D; Moore D; Song F
    Health Technol Assess; 2007 Oct; 11(38):iii-iv, ix-66. PubMed ID: 17903392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
    Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
    Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance.
    Bobade RA; Helmers RA; Jaeger TM; Odell LJ; Haas DA; Kaplan RS
    J Med Econ; 2019 May; 22(5):471-477. PubMed ID: 30744455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
    Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML
    Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.
    Chiquette E; Amato MG; Bussey HI
    Arch Intern Med; 1998 Aug 10-24; 158(15):1641-7. PubMed ID: 9701098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.
    Meckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DL
    Pharmacoeconomics; 2010; 28(1):61-74. PubMed ID: 20014877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.
    Kantito S; Saokaew S; Yamwong S; Vathesatogkit P; Katekao W; Sritara P; Chaiyakunapruk N
    J Thromb Thrombolysis; 2018 Feb; 45(2):281-290. PubMed ID: 29181693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a new method of warfarin management on patient satisfaction, time, and cost.
    Meyer S; Frei CR; Daniels KR; Forcade NA; Bussey M; Bussey-Smith KL; Bussey HI
    Pharmacotherapy; 2013 Nov; 33(11):1147-55. PubMed ID: 24038425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomes.
    Mittmann N; Oh PI; Walker SE; Bartle WR
    Pharmacoeconomics; 2004; 22(10):671-83. PubMed ID: 15244492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
    Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
    Bloomfield HE; Krause A; Greer N; Taylor BC; MacDonald R; Rutks I; Reddy P; Wilt TJ
    Ann Intern Med; 2011 Apr; 154(7):472-82. PubMed ID: 21464349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
    Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
    Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in Anticoagulation.
    Stevanović J; Postma MJ; Le HH
    Value Health; 2016 Jun; 19(4):383-90. PubMed ID: 27325330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost considerations surrounding current and future anticoagulant therapies.
    Fang MC; Minichiello T; Auerbach AD
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S43-9. PubMed ID: 15853179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.